Eleven hospitals put on notice
July 17, 2013Sales and Marketing Hunt, Labour, Mid Staffs, NHS, burnham, keogh
There were angry exchanges in the House of Commons yesterday as health secretary Jeremy Hunt announced that 11 hospitals in …
WinchPharma appoints new chief executive
July 17, 2013Manufacturing and Production, Research and Development, Sales and Marketing lyndon nicholson, winchpharma
Healthcare products firm WinchPharma has appointed Lyndon Nicholson as its new chief executive with immediate effect. Nicholson will replace former …
Dementia rates declining in UK
July 17, 2013Research and Development, Sales and Marketing Alzheimer's, UK, brain, dementia
A new study has found that the rate of dementia in Britain has decreased over the past two decades, contrary …
GSK exec admits bribery on live TV
July 16, 2013Medical Communications, Sales and Marketing China, GSK, bribery, cctv
A senior member of GSK China has appeared on state television admitting the firm’s guilt in the ongoing bribery allegations. …
Ipsen buys Syntaxin
July 16, 2013Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi
French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …
Roche ‘considers’ Alexion bid
July 16, 2013Research and Development, Sales and Marketing Alexion, Orphan, Roche, soliris
Speculation that Roche is considering a bid for rare disease specialist Alexion Pharmaceuticals has unleashed a flurry of comment – …
The pharma industry in the public imagination
July 16, 2013Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Adams, image, literary, pharma
Popular culture in both films and literature depict pharma and scientists as part of a nefarious industry, hell bent on …
NICE rejects Pfizer blood cancer drug
July 16, 2013Sales and Marketing BMS, CML, NICE, Pfizer, bosulif
NICE is not recommending Pfizer’s blood cancer drug Bosulif due to uncertainties over its cost effectiveness and survival benefit. In …
Aesica appoints two new business development managers
July 16, 2013Manufacturing and Production, Research and Development, Sales and Marketing Aesica, ross, thomas
Contract development and manufacturing organisation Aesica has appointed Sven Thomas and David Ross as business development managers. Under the new …
Irish eyes smiling as Pfizer plans $130m investment
July 15, 2013Manufacturing and Production IDA, Pfizer, cork, grange
The company has said it will spend $100m upgrading its Grange Castle site in Dublin and $30m at Ringaskiddy in …
Lilly revisits Alzheimer’s drug
July 15, 2013Research and Development, Sales and Marketing Alzheimer's, lilly, solanezumab
Eli Lilly & Co is to run yet another trial of its Alzheimer’s drug solanezumab, which failed twice in Phase …
Roche’s Erivedge gains conditional EU approval
July 15, 2013Sales and Marketing Curis, EU, Erivedge, Roche, Swiss, Zelboraf
Roche’s cancer pill Erivedge has received a conditional European approval for treatment of the most common type of skin cancer. …
Next generation digital firms for Europe wanted
July 15, 2013Medical Communications, Sales and Marketing J&J, JJ, digital, innovation
Digital health start-ups from across Europe are being called on to form a part of Johnson & Johnson Innovation’s inaugural …
Simon Lowth exits AstraZeneca
July 15, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, simon lowth
AstraZeneca’s chief financial officer and executive director Simon Lowth will leave the firm at the end of October. Lowth has …
FDA approves Boehringer’s lung cancer drug
July 12, 2013Medical Communications, Sales and Marketing Boehringer, FDA, Roche, Tarceva, afatinib, lung cancer
Boehringer Ingelheim’s late-stage lung cancer drug Gilotrif has received an accelerated FDA approval for patients with a certain genetic mutation. …
UK science future looking brighter – survey
July 12, 2013Research and Development, Sales and Marketing UCB, science
A new survey undertaken by UCB has found that enthusiasm for science in the UK is high, but adds that …
Eliquis poised for new US approval
July 12, 2013Sales and Marketing BMS, Bayer, DVT, Eliquis, warfarin
Pfizer and Bristol-Myers Squibb have submitted their oral direct Factor Xa inhibitor Eliquis to the FDA to prevent deep vein …
Eisai backs disease fund
July 12, 2013Research and Development, Sales and Marketing Eisai, Japan, TB, partnership
A leading Japanese pharma group says that the sector should see investment in fighting diseases of the developing world as …
China accuses GSK of large scale bribery
July 12, 2013Medical Communications, Research and Development, Sales and Marketing Avandia, China, GSK, Seroxat
Health officials in China say they have found evidence GSK tried to generate sales and raise drug prices by bribing …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
